Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. [electronic resource]
Producer: 20170410Description: 3106-3108 p. digitalISSN:- 1873-2623
- Abatacept -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Atypical Hemolytic Uremic Syndrome -- complications
- Calcineurin Inhibitors -- adverse effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- adverse effects
- Male
- Plasmapheresis -- adverse effects
- Postoperative Complications -- chemically induced
- Thrombotic Microangiopathies -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.